Exploring the use of psychedelics as pain management options with a particular focus on microdosing: a collaboration between the Beckley Foundation and the Department of Neuropsychopharmacology and Psychopharmacology – Maastricht University.
This survey is now closed. The data is currently being analysed and results will be published in the first half of 2022. The team at the Beckley/Maastricht Research Programme would like to thank everybody for their participation
Microdosing, which involves taking small amounts of psychedelic substances, has gained momentum for its psychological benefits including enhanced mood, focus and cognition.
Although some anecdotal evidence suggests that microdosing, under certain circumstances, may be beneficial for pain management, there has not been enough clinical research to examine the validity of this claim.
This preliminary survey aimed to address this question, and take the first step towards a better understanding of the relationship between psychedelic microdosing and pain.
The Beckley Foundation relies exclusively on the generosity of our supporters. Donations of any amount are greatly appreciated and help us develop and expand our science, policy and outreach programmes.
Psilocybin for Depression
Type of publication